Autor segons l'article: Costa B; Barrio F; Piñol J; Cabré J; Mundet X; Sagarra R; Salas-Salvadó J; Solà-Morales O
Departament: Bioquímica i Biotecnologia
Autor/s de la URV: Bulló Bonet, Mònica / Salas Salvadó, Jorge
Paraules clau: Type-2 Type 2 diabetes Tools Style intervention Screening Primary healthcare Pre-diabetes Mellitus Individuals Impaired glucose tolerance Impaired fasting glucose Findrisc
Resum: Background: To investigate differences in the performance of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for glucose abnormalities after shifting from glucose-based diagnostic criteria to the proposed new hemoglobin (Hb)A1c-based criteria.Methods: A cross-sectional primary-care study was conducted as the first part of an active real-life lifestyle intervention to prevent type 2 diabetes within a high-risk Spanish Mediterranean population. Individuals without diabetes aged 45-75 years (n = 3,120) were screened using the FINDRISC. Where feasible, a subsequent 2-hour oral glucose tolerance test and HbA1c test were also carried out (n = 1,712). The performance of the risk score was calculated by applying the area under the curve (AUC) for the receiver operating characteristic, using three sets of criteria (2-hour glucose, fasting glucose, HbA1c) and three diagnostic categories (normal, pre-diabetes, diabetes).Results: Defining diabetes by a single HbA1c measurement resulted in a significantly lower diabetes prevalence (3.6%) compared with diabetes defined by 2-hour plasma glucose (9.2%), but was not significantly lower than that obtained using fasting plasma glucose (3.1%). The FINDRISC at a cut-off of 14 had a reasonably high ability to predict diabetes using the diagnostic criteria of 2-hour or fasting glucose (AUC = 0.71) or all glucose abnormalities (AUC = 0.67 and 0.69, respectively). When HbA1c was used as the primary diagnostic criterion, the AUC for diabetes detection dropped to 0.67 (5.6% reduction in comparison with either 2-hour or fasting glucose) and fell to 0.55 for detection of all glucose abnormalities (17.9% and 20.3% reduction, respectively), with a relevant decrease in sensitivity of the risk score.Conclusions: A shift from glucose-based diagnosis to HbA1c-based diagnosis substantially reduces the ability of the FINDRISC to screen for glucose abnormalities when applied in this real-life primary-care preventive strategy. © 2013 Costa et al; licensee BioMed Central Ltd.
Àrees temàtiques: Saúde coletiva Medicine, general & internal Medicine (miscellaneous) Medicine (all) Medicina veterinaria Medicina ii Medicina i General medicine Ciências biológicas iii Ciências biológicas ii Ciências biológicas i
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
Adreça de correu electrònic de l'autor: jordi.salas@urv.cat monica.bullo@urv.cat
Identificador de l'autor: 0000-0003-2700-7459 0000-0002-0218-7046
Data d'alta del registre: 2023-02-18
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
Enllaç font original: https://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-11-45
URL Document de llicència: http://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: Bmc Medicine. 11 (1): 45-
Referència de l'ítem segons les normes APA: Costa B; Barrio F; Piñol J; Cabré J; Mundet X; Sagarra R; Salas-Salvadó J; Solà-Morales O (2013). Shifting from glucose diagnosis to the new HbA1c diagnosis would reduce the ability of the Finnish Diabetes Risk Score (FINDRISC)in screening glucose abnormalities within a real-life primary healthcare preventive strategy.. Bmc Medicine, 11(1), 45-. DOI: 10.1186/1741-7015-11-45
DOI de l'article: 10.1186/1741-7015-11-45
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2013
Tipus de publicació: Journal Publications
Repositori URV